Quarterly report pursuant to Section 13 or 15(d)

Principal Business Activity and Basis of Presentation (Details Narrative)

v3.7.0.1
Principal Business Activity and Basis of Presentation (Details Narrative)
$ / shares in Units, $ in Thousands
6 Months Ended
Apr. 07, 2017
USD ($)
$ / shares
shares
Jan. 31, 2017
USD ($)
Apr. 30, 2017
USD ($)
Segments
shares
Apr. 30, 2016
USD ($)
Oct. 31, 2016
shares
Convertible preferred stock, shares authorized     10,000,000   10,000,000
Payments to acquire medical equipment | $   $ 1,400 $ 1,961  
Number of operating segments | Segments     2    
Regenerative medicine expense | $     $ 40,000,000    
Sales [Member] | Sony [Member]          
Concentration risk, percentage     33.00% 28.00%  
Sales [Member] | Microsoft [Member]          
Concentration risk, percentage     29.00% 40.00%  
Sales [Member] | Entrophy [Member]          
Concentration risk, percentage     13.00%    
Sales [Member] | Valve [Member]          
Concentration risk, percentage     11.00% 18.00%  
Sales [Member] | Zumba Fitness Games [Member]          
Concentration risk, percentage     11.00% 10.00%  
Accounts Receivable [Member] | Sony [Member]          
Concentration risk, percentage     43.00%    
Accounts Receivable [Member] | Microsoft [Member]          
Concentration risk, percentage     23.00%    
Series E Preferred Stock [Member]          
Convertible preferred stock, shares authorized 7,050        
Number of convertible into an aggregate shares of common stock 7,050,000        
Number of convertible into an aggregate value of common stock | $ $ 104,700        
Number of preferred stock convertible into common stock 7,050,000        
Common stock closing price per share | $ / shares $ 14.85